Search Results

Mebgovib ER 25 - Mirabegron 25 mg

MEBGOVIB ER 25 "MIRABEGRON 25mg. IP

Send Enquiry

GENVIMAX

Tablets

Packaging and packing Type

Alu Alu | 10x10

MRP :

₹229

PTR :

₹174.48

PTS :

₹157.03

Prescription medicineMebgovib ER 25 tablets contain Mirabegron 25 mg and are used to treat overactive bladder symptoms such as urgency, frequency and urge leakage. Read More

Composition

MIRABEGRON 25mg. IP

Send Enquiry

India’s Trusted Pharma Brand

100%

Genuine Products

Secure

Payments

24 x 7

Customer Support

About the product

By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references

Description

Mebgovib ER 25 is a tablet form of medicine from Vibcare Pharma. Each tablet carries Mirabegron 25 mg as its active ingredient. It belongs to the beta-3 adrenergic agonist class of medicines used in urology. The brand is packed as 10x10 (Alu Alu) and is supplied from Vibcare Pharma's Genvimax division.

How it works

The medicine works on the bladder during the filling stage. Mirabegron acts on beta-3 adrenergic receptors and relaxes the detrusor smooth muscle of the bladder. With this muscle relaxed, the bladder can hold a larger amount of urine before the urge to pass urine is felt, and the bladder capacity is increased.

Used for

Mebgovib ER 25 tablets are used for overactive bladder in adults who have urge urinary incontinence, urgency or frequent urination.

Use only on a doctor's prescription, at the dose and for the duration advised.

Side Effects

Common

  • High blood pressure
  • Nasopharyngitis (irritation or infection of the nose and throat)
  • Urinary tract infection
  • Headache

Get medical help at once if you notice

  • Angioedema (swelling of the face, lips, tongue or larynx)
  • Severe allergic reaction to the medicine
  • Urinary retention (inability to pass urine)

Uses

  • Treatment of overactive bladder in adult patients
  • Relief of urge urinary incontinence (leakage with a sudden urge to pass urine)
  • Relief of urgency (sudden, hard-to-hold urge to pass urine)
  • Relief of urinary frequency (passing urine more often than usual)

Precautions

Do not use

  • Must not be used by patients with known hypersensitivity (allergy) to mirabegron or to any inactive ingredient of the tablet

Ask a doctor first

  • Check with a doctor first if blood pressure is very high and not controlled (systolic 180 mm Hg or more and/or diastolic 110 mm Hg or more); use is not recommended in such patients
  • Check with a doctor first if there is bladder outlet obstruction, because of the risk of urinary retention
  • Check with a doctor first if you are taking an antimuscarinic medicine for overactive bladder, because of the risk of urinary retention
  • Check with a doctor first if you have high blood pressure; blood pressure should be monitored from time to time

Mebgovib ER 25 Tablet: frequently asked questions

What is Mebgovib ER 25 Tablet used for?

Mebgovib ER 25 tablets contain Mirabegron 25 mg and are used to treat overactive bladder symptoms such as urgency, frequency and urge leakage. Main uses: treatment of overactive bladder in adult patients; relief of urge urinary incontinence (leakage with a sudden urge to pass urine); relief of urgency (sudden, hard-to-hold urge to pass urine); relief of urinary frequency (passing urine more often than usual).

What are the side effects of Mebgovib ER 25 Tablet?

Common side effects of Mebgovib ER 25 Tablet include high blood pressure; nasopharyngitis (irritation or infection of the nose and throat); urinary tract infection; headache. Get medical help at once if you notice angioedema (swelling of the face, lips, tongue or larynx); severe allergic reaction to the medicine; urinary retention (inability to pass urine).

What is the dose of Mebgovib ER 25 Tablet?

Each Mebgovib ER 25 tablet contains Mirabegron 25 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Mebgovib ER 25 Tablet only as your doctor advises.

What is the price of Mebgovib ER 25 Tablet?

The MRP of Mebgovib ER 25 Tablet is ₹229 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹174.48 and the PTS is ₹157.03.

What is the composition of Mebgovib ER 25 Tablet?

Each Mebgovib ER 25 tablet contains Mirabegron 25 mg. It comes in a pack of 10x10 (Alu Alu).

How does Mebgovib ER 25 Tablet work?

The medicine works on the bladder during the filling stage. Mirabegron acts on beta-3 adrenergic receptors and relaxes the detrusor smooth muscle of the bladder. With this muscle relaxed, the bladder can hold a larger amount of urine before the urge to pass urine is felt, and the bladder capacity is increased.

Who should not use Mebgovib ER 25 Tablet?

Must not be used by patients with known hypersensitivity (allergy) to mirabegron or to any inactive ingredient of the tablet. Check with a doctor first if blood pressure is very high and not controlled (systolic 180 mm Hg or more and/or diastolic 110 mm Hg or more); use is not recommended in such patients. Check with a doctor first if there is bladder outlet obstruction, because of the risk of urinary retention. Check with a doctor first if you are taking an antimuscarinic medicine for overactive bladder, because of the risk of urinary retention. Check with a doctor first if you have high blood pressure; blood pressure should be monitored from time to time.

Who markets Mebgovib ER 25 Tablet, and is it available for PCD franchise?

Mebgovib ER 25 Tablet is a brand of Vibcare Pharma, sold through its Genvimax division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.

Looking into the future of healthcare

Contact

Plot No 4, HSIIDC IT PARK, Sector 22,Panchkula, Haryana, India 134109

Phone: 9888988858

Business Hours

Mon-Sat: 9AM to 6PM

Business Enquiry

Request a callback to get more information about becoming a Partner

    Send Enquiry

    Request a callback to get more information about becoming a PCD Franchise Owner

    Please enable JavaScript in your browser to complete this form.
    Do you have a Drug License?